*Bijay Parajuli^1,2, Eiji Shigetomi^1,2, Schuichi Koizumi^1,2 (1. Yamanashi Glia Center, 2. Dept Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi)

*Toma Adachi¹, Kentaro Ichijo², Tomoo Owa³, Satoshi Miyashita¹, Ikuko Hasegawa¹, Kyoka Suyama¹, Kaiyuan Ji ¹, Minami Mizuno¹, Yuriko Nishizaki⁴, Yukiko Inoue¹, Takuro Nakamura⁵, Takayoshi Inoue¹, Mikio Hoshino¹ (1. Dept of Biochem. and Cell. Biol, Natl. Ctr. Of Neurol. And Psychiatry (NCNP), 2. Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, The University of Tokyo, 3. Graduate School of Medicine, Faculty of Medicine, Osaka University, 4. Laboratory of Biochemistry Yokohama University of Pharmacy, 5. Cancer Institute, Japanese Foundation for Cancer Research)

*Chikage Kijima¹, Toshiki Inaba¹, Kenichiro Hira¹, Nobukazu Miyamoto¹, Kazuo Yamashiro², Takao Urabe², Yuji Ueno³, Nobutaka Hattori^1,4 (1. Department of Neurology, Juntendo University School of Medicine, 2. Department of Neurology, Juntendo University Urayasu Hospital, 3. Department of Neurology, University of Yamanashi, 4. Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science)

*Yuki Wakayama¹, Thi Phuong Hoai Dinh ¹, Kohji Sato¹, Satoru Yamagishi² (1. Hamamatsu University School of Medicine, 2. Hamamatsu University School of Medicine)